FindTrial
Sign In

The prognostic effect of anatomic versus non-anatomic resection for hepatocellular carcinoma--A randomized controlled trial

The prognostic effect of anatomic versus non-anatomic resection for hepatocellular carcinoma--A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000073
Enrollment
Unknown
Registered
2008-03-31
Start date
2006-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma.

Interventions

anatomic resection group:Anatomic Hepatectomy for Hepatocellular Carcinoma
non-anatomic resection group:Non-anatomic Hepatectomy for Hepatocellular Carcinoma

Sponsors

Southwest Hospital, The Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) hepatocellular carcinoma patients; (2) hepatic function: Child-A, ICGR-15 <14%; (3) no more than 2 tumors and limted in semi-liver; (4) no metastasis out of the liver; (5) heart, lung, and kidney functions are normal, respectively.

Exclusion criteria

Exclusion criteria: (1) Preoperative imageology shows tumor thrombus in liver; (2) hepatic function: Child-B or Child-C; (3) caudal lobe tumor; (4) have organ diseases cannot tolerate the surgery;(5)chemotherapy and/or radiotherapy less than 6 weeks.

Design outcomes

Primary

MeasureTime frame
recurrence rate;disease-free survival rate;overall survival rate;—

Secondary

MeasureTime frame
operation complication, liver function, pathological indexes, AFP mRNA in peripheral blood;—

Countries

China

Contacts

Public ContactFeng Xia
drfxia@hotmail.com+86 023 68765797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026